RB1 and neoplasm: In the era of translational medicine, the identification of specific tumor markers and genes involved in oncogenesis, above all EGFR, VEGF, TP53, and pRB pathways, offers new insights to design the target gene strategies and tumor suppressor gene therapies [22].